Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Climb Bio, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 76 | 69 | −7 |
| Shares | 51.9M | 49.9M | −2.04M (−3.9%) |
| Value | $63.4M | $61.9M | −$1.50M (−2.4%) |
New holders (19)
Institutions that held Climb Bio, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 485,364 | $601.9K | 0.00% |
| Nan Fung Trinity (HK) Ltd | 463,654 | $574.9K | 0.07% |
| Jane Street Group, LLC | 148,180 | $183.7K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 127,952 | $158.7K | 0.00% |
| Stonepine Capital Management, LLC | 116,147 | $144.0K | 0.14% |
| Cubist Systematic Strategies, LLC | 62,176 | $77.1K | 0.00% |
| Marshall Wace, LLP | 36,738 | $45.6K | 0.00% |
| Qube Research & Technologies Ltd | 34,310 | $42.5K | 0.00% |
| Jain Global LLC | 25,693 | $31.9K | 0.00% |
| Squarepoint Ops LLC | 19,640 | $24.4K | 0.00% |
| HRT Financial LP | 18,529 | $22.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 14,085 | $17.5K | 0.00% |
| Deutsche Bank AG | 12,382 | $15.4K | 0.00% |
| Nisa Investment Advisors, LLC | 573 | $711 | 0.00% |
| Point72 (DIFC) Ltd | 421 | $522 | 0.00% |
| Advisor Group Holdings, Inc. | 295 | $360 | 0.00% |
| Raymond James Financial Inc | 200 | $248 | 0.00% |
| Essential Partners LLC | 63 | $78 | 0.00% |
| Clearstead Advisors, LLC | 11 | $14 | 0.00% |
Sold out (26)
Institutions that held Climb Bio, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.